Radoslaw Stefan Rusyniak

7PUBLICATIONS
8CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 14, 2026
Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation.

Mohammad Fayyad-Kazan, Sarah Al-Tameemi, Allal Ouhtit

|Apr 13, 2023
Docosahexaenoic Acid, a Key Compound for Enhancing Sensitization to Drug in Doxorubicin-Resistant MCF-7 Cell Line.

Sergio Crovella, Allal Ouhtit, Shaikh Mizanoor Rahman

|Feb 15, 2022
<i>SOD2</i>, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression.

Nouralhuda Alateyah, Ishita Gupta, Radoslaw Stefan Rusyniak

|Jan 24, 2021
KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion.

Maryam Al-Mansoob, Ishita Gupta, Radoslaw Stefan Rusyniak

|Sep 05, 2020
Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion.

Balsam Rizeq, Saïd Sif, Gheyath K Nasrallah

Pageof 2